TABLE S1.

Age- and sex-adjusted risk factor prevalence among symptomatic Canadian REduction of Atherothrombosis for Continued Health (REACH) Registry patients

	Canada (n=1631)	British Columbia (n=134)	Prairies* (n=327)	Ontario (n=632)	Quebec (n=435)	Maritimes†(n=103)
Diabetes‡, %	35.3	42.6	27.8§	35.7	33.5	53.0¶
Hypertension**, %	74.9	84.1§	67.8§	77.5§	74.6	68.8
Hypercholesterolemia, %	84.1	91.8§	78.3¶	83.8	87.0	86.4
Abdominal obesity††, %	49.7	47.7	56.5§	44.2§	46.5	55.5
Overweight (BMI 25 kg/m2 to <30 kg/m2), %	41.8	45.0	44.2	42.9	38.0	43.9
Obesity, %
Class I (BMI 30 kg/m2 to <35 kg/m2)	22.5	19.9	26.3	21.3	22.9	19.2
Class II (BMI 35 kg/m2 to <40 kg/m2)	6.2	5.3	7.2	4.8	5.6	10.1
Class III (BMI ≥40 kg/m2)	2.4	3.4	1.8	2.6	1.4	1.9
Smoking, %
Former‡‡	47.6	54.5	55.3	46.0	48.0	53.6
Current§§	12.6	5.4§	8.3§	11.1	19.1¶	16.0
Modified metabolic syndrome¶¶, %	24.6	19.2	21.2	21.9	28.2§	36.2§
Impaired fasting glucose***, %	22.9	25.8	22.8	21.6	22.6	27.9

The overall P-values across the regions were not significant for the following categories: overweight, obesity, former smoker and impaired fasting glucose; therefore, no pair-wise comparisons were performed.

^*Alberta, Manitoba and Saskatchewan;

^†Newfoundland and Labrador, Prince Edward Island, Nova Scotia and New Brunswick;

^‡Patients with type 1 or 2 diabetes currently treated with hypoglycemic agents or a history of diabetes;

^§0.001<P<0.05;

^¶P<0.001;

^**Patients with systolic blood pressure ≥150 mmHg despite therapy for ≥3 months or a history of hypertension;

^††Men: waist circumference ≥102 cm; women: waist circumference ≥88 cm;

^‡‡≥5 cigarettes/day (mean) >1 month before enrolment;

^§§≥5 cigarettes/day (mean) within 1 month of enrolment;

^¶¶Patients with ≥3 of the following: abdominal obesity, triglycerides ≥1.7 mmol/L, blood pressure ≥130/85 mmHg, fasting glucose >6.1 mmol/L;

^***Patients with fasting glucose >5.6 mmol/L and <7.0 mmol/L. BMI Body mass index